Long distance transport for primary ansioplasty vs immediate thrombolysis in acute myocardial infarction (PRAGUE-2 trial) [3]

European Heart Journal

Volumn 24, Issue 19, 2003, Pages 1798-1799

  De Arenaza, Dego Perez ^b   Taneja, Anil K ^a,b   Flather, Marcus ^b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CLINICAL PROTOCOL; CORONARY ARTERY DILATATION; HUMAN; LETTER; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; PUBLICATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VALIDATION PROCESS;

ANGIOPLASTY; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; TRANSPORTATION OF PATIENTS; TREATMENT OUTCOME;

EID: 0141951916     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.06.001     Document Type: Letter

References (5)

1. Widimsky P, Budesinsky T, Vorac D et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PPAGUE-2. Eur Heart J 2003;24(1):94-104.
2. Zijlstra F. Ansioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. Eur Heart J 2003;24(1):21-3.
3. Keeley EC, Boura JA, Grines CL. Primary angioptasty versus intravenous thrombotytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2002;361:13.
4. Moon JC, Kalra PR, Coats AJ. DANAMI-2: is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? Int J Cardiol 2002;85(2-3):199-201.
5. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.